Recombinant IL22 (Fezakinumab Biosimilar) antibody

Catalog No. ABIN7597689

This Human Monoclonal antibody specifically detects IL22 (Fezakinumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant IL22 (Fezakinumab Biosimilar) antibody (ABIN7597689)

Target: IL22 (Fezakinumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL22 (Fezakinumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL22 (Fezakinumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Fezakinumab Biosimilar Antibody

Specificity: Interleukin-22, Cytokine Zcyto18, IL-22, ZCYTO18, IL22, ILTIF, IL-TIF, IL-10-related T-cell-derived-inducible factor

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 lambda

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL22 (Fezakinumab Biosimilar)

Target: IL22 (Fezakinumab Biosimilar)

Alternative Name: Fezakinumab Biosimilar

Target Type: Biosimilar

Background: Interleukin-22, Cytokine Zcyto18, IL-22, ZCYTO18, IL22, ILTIF, IL-TIF, IL-10-related T-cell-derived-inducible factor

UniProt: Q9GZX6

CAS-No: 1007106-86-6